tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Rigel Pharmaceuticals price target raised to $71 from $69 at Citi
PremiumThe FlyRigel Pharmaceuticals price target raised to $71 from $69 at Citi
2M ago
Rigel: Strengthening Commercial Trajectory, Clear Path to 2026 Profitability, and Advancing Pipeline Support Buy Rating
Premium
Ratings
Rigel: Strengthening Commercial Trajectory, Clear Path to 2026 Profitability, and Advancing Pipeline Support Buy Rating
2M ago
Rigel Announces Strong Preliminary 2025 Results and Outlook
Premium
Company Announcements
Rigel Announces Strong Preliminary 2025 Results and Outlook
2M ago
Rigel Pharmaceuticals announces updated data from Phase 1b study of R2891
PremiumThe FlyRigel Pharmaceuticals announces updated data from Phase 1b study of R2891
3M ago
Rigel Pharmaceuticals’ olutasidenib shows efficacy in Phase 2 AML trial
Premium
The Fly
Rigel Pharmaceuticals’ olutasidenib shows efficacy in Phase 2 AML trial
4M ago
Rigel Pharmaceuticals Reports Record Q3 Revenue and Growth
Premium
Company Announcements
Rigel Pharmaceuticals Reports Record Q3 Revenue and Growth
4M ago
Rigel Pharmaceuticals Reports Strong Q3 2025 Results
PremiumCompany AnnouncementsRigel Pharmaceuticals Reports Strong Q3 2025 Results
4M ago
Rigel Pharmaceuticals reports Q3 EPS $1.46, consensus 94c
Premium
The Fly
Rigel Pharmaceuticals reports Q3 EPS $1.46, consensus 94c
4M ago
Rigel Pharmaceuticals raises FY25 revenue view to $285M-$290M from $270M-$280M
Premium
The Fly
Rigel Pharmaceuticals raises FY25 revenue view to $285M-$290M from $270M-$280M
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100